Last reviewed · How we verify
NCT04016025: AD-HERE
A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers
Phase 4 trial testing Adherence to topical standard therapy assessed in Adherence, Patient in 80 participants. Completed in 14 April 2022.
11 March 2022
Quick facts
| Lead sponsor | Jena University Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 2 December 2020 |
| Primary completion | 11 March 2022 |
| Estimated completion | 14 April 2022 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Adherence to topical standard therapy assessed
Conditions studied
- Adherence, Patient — all drugs for Adherence, Patient →
- Chronic Eczema — all drugs for Chronic Eczema →
Sponsor
Jena University Hospital
Who can join
Adults 18 to 65, any sex, with Adherence, Patient or Chronic Eczema. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Untersuchung der Adhärenz zur topischen Standardtherapie bei Patienten mit chronischem Handekzem in Abhängigkeit von der Galenik
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04016025
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adherence, Patient
Currently open trials in the same condition.
- NCT07261553 — Adherence to Home-Based Exercises in Musculoskeletal Disorders · recruiting
- NCT05613010 — Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant · NA · recruiting
- NCT05832008 — Increasing Adherence to Lung Cancer Screening · NA · active not recruiting
- NCT05448560 — A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship · NA · active not recruiting
- NCT04298905 — Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA · NA · active not recruiting
Other Jena University Hospital trials
Trials by the same sponsor.
- NCT06355050 — Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer · not yet recruiting
- NCT06749483 — The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units? · recruiting
- NCT06765551 — AI Based Muscular Ultrasound to Assess Intensive Care Unit-acquired Weakness · recruiting
- NCT06539377 — Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma · NA · not yet recruiting
- NCT07428226 — Serum Bile Acid Profiles in Patients With Intrahepatic Cholestasis of Pregnancy · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04016025 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jena University Hospital
- Last refreshed: 10 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04016025.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing